HIV-Network

HIV-Network

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from HIV-Network, Community Organization, .

The HIV-Network was conceptualized as an e-platform by a group of IDUs and people living with HIV to discuss problems/issues confronting this community for bringing a tangible solution through online services.Visit www.hiv-network.com

Managing multiple health conditions 28/09/2022

https://www.aidsmap.com/about-hiv/managing-multiple-health-conditions?fbclid=IwAR2Db8zgdH-L91foJggCcV0IuVuD4K6opCpE9ib1IF2yU19-l5GXghC9aZM

Managing multiple health conditions Many people living with HIV have other health conditions as well. You may need to see a number of different doctors and go to more than one clinic for your healthcare needs. This page gives general information about managing multiple chronic conditions.

How a 4th Person Was ‘Cured’ of HIV After Stem Cell Treatments 04/09/2022

https://www.healthline.com/health-news/how-a-4th-person-was-cured-of-hiv-after-stem-cell-treatments

How a 4th Person Was ‘Cured’ of HIV After Stem Cell Treatments A 66-year-old man who was living with HIV and leukemia is now in long-term remission from both the virus and blood cancer following a successful stem cell transplant from a donor who possesses an extremely rare genetic mutation. Here's what that could mean for the future of HIV treatment.

Zambian patients on dolutegravir and recycled tenofovir regimens have high risk of TB even after switch 31/08/2022

https://www.aidsmap.com/news/aug-2022/zambian-patients-dolutegravir-and-recycled-tenofovir-regimens-have-high-risk-tb-even?utm_source=dlvr.it&utm_medium=facebook

Zambian patients on dolutegravir and recycled tenofovir regimens have high risk of TB even after switch A study conducted among people on regimens of dolutegravir and recycled tenofovir in Zambia shows tuberculosis remains a deadly threat in the months after switching treatment and is a risk factor for poor viral suppression. The study presented at the recent 24th International AIDS Conference (AIDS 2...

United BioPharma gets FDA approval for phase 2 HIV drug trial 31/08/2022

https://www.labiotech.eu/trends-news/united-biopharma-hiv-drug-trial/

United BioPharma gets FDA approval for phase 2 HIV drug trial United BioPharma says the FDA has approved a clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases.

USask research teams to test treatments for eliminating HIV infection, fibrotic diseases 30/08/2022

https://news.usask.ca/articles/research/2022/usask-research-teams-to-test-treatments-for-eliminating-hiv-infection,-fibrotic-diseases.php

USask research teams to test treatments for eliminating HIV infection, fibrotic diseases Research to explore the effectiveness of innovative targeted treatments for HIV infections, and the use of protein therapy to break down fibrous scar tissue are two of five new University of Saskatchewan (USask) projects awarded a total of $3.3 million in federal funding.

Scientists zero in on antibodies capable of neutralizing HIV 28/08/2022

https://medicalxpress.com/news/2022-08-scientists-antibodies-capable-neutralizing-hiv.html

Scientists zero in on antibodies capable of neutralizing HIV More than 40 years into the HIV pandemic, scientists are shedding new light on how defenses are mounted against the virus, discoveries that may eventually lead to a neutralizing antibody that stops the virus before it becomes an immune-crippling menace.

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them 28/08/2022

https://www.aidsmap.com/news/aug-2022/just-six-injections-year-can-prevent-hiv-heres-what-it-will-take-world-afford-them

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them An injection every two months of the antiretroviral cabotegravir is the most effective way to prevent HIV that the world has ever seen. Making it affordable will depend, in part, on how many generic manufacturers will invest in producing it — and for that, the world must show the promise of market...

European Commission approves first twice-yearly HIV medication 26/08/2022

https://www.aidsmap.com/news/aug-2022/european-commission-approves-first-twice-yearly-hiv-medication?utm_source=dlvr.it&utm_medium=facebook

European Commission approves first twice-yearly HIV medication This week the European Commission became the first regulatory agency to approve Gilead Sciences’ long-acting HIV capsid inhibitor lenacapavir, to be marketed as Sunlenca. The twice-yearly antiretroviral is indicated for treatment-experienced people with multidrug-resistant HIV who cannot otherwise...

A cure must be a cure for all: why more HIV cure research in Africa is needed 23/08/2022

https://www.aidsmap.com/news/aug-2022/cure-must-be-cure-all-why-more-hiv-cure-research-africa-needed

A cure must be a cure for all: why more HIV cure research in Africa is needed Only one in eight HIV cure studies are being conducted in sub-Saharan Africa, but a few important studies have got off the ground in recent years. In South Africa, young women with very recent infection are testing broadly neutralising antibodies and vesatolimod, while gene therapy research is under...

We still have no HIV cure. But we have a better strategy for finding one 16/08/2022

https://www.aidsmap.com/news/aug-2022/we-still-have-no-hiv-cure-we-have-better-strategy-finding-one

We still have no HIV cure. But we have a better strategy for finding one There are many pre-conference meetings that lead up to each International AIDS Society conference. One of the most eagerly awaited, by researchers and treatment activists alike, is run by the Towards an HIV Cure research consortium.

From Treatment To Prevention To A Cure: An Interview With Gilead’s HIV R&D Leaders 12/08/2022

https://scrip.pharmaintelligence.informa.com/SC146872/From-Treatment-To-Prevention-To-A-Cure-An-Interview-With-Gileads-HIV-RD-Leaders

From Treatment To Prevention To A Cure: An Interview With Gilead’s HIV R&D Leaders Gilead execs Jared Baeten and Tomas Cihlar talk to Scrip about how the company, still the leader in HIV, is working toward less-frequent dosing, providing PrEP for broader populations and maybe finding a cure for HIV infection.

AIDS 2022: Scientists report progress in understanding how to eliminate latent HIV reservoirs 10/08/2022

https://www.bioworld.com/articles/521480-aids-2022-scientists-report-progress-in-understanding-how-to-eliminate-latent-hiv-reservoirs

AIDS 2022: Scientists report progress in understanding how to eliminate latent HIV reservoirs Researchers around the world are making advances in understanding how HIV becomes latent and seeking out vulnerabilities that could provide routes to targeting reservoirs and eliminating them.

University of São Paulo: Fourth case of HIV cure reignites hopes for vaccine against the virus | India Education | Latest Education News | Global Educational News | Recent Educational News 09/08/2022

https://indiaeducationdiary.in/university-of-sao-paulo-fourth-case-of-hiv-cure-reignites-hopes-for-vaccine-against-the-virus/

University of São Paulo: Fourth case of HIV cure reignites hopes for vaccine against the virus | India Education | Latest Education News | Global Educational News | Recent Educational News AcademicsInternational NewsUniversity News University of São Paulo: Fourth case of HIV cure reignites hopes for vaccine against the virus By iednewsdesk - August 9, 2022 Facebook Twitter Pinterest WhatsApp During the International AIDS Conference , which took place on July 27, held in Washington, U...

Fourth Patient Seemingly Cured of HIV Through Wild Coincidence 09/08/2022

https://www.goodnewsnetwork.org/fourth-patient-seemingly-cured-of-hiv-through-wild-coincidence/

Fourth Patient Seemingly Cured of HIV Through Wild Coincidence The media continues the one-handed count of patients that seem to be cured of HIV as a man has stayed in remission for 17 months.

2 more people have been 'cured' of HIV — 1 man thanks to cancer treatment, and 1 woman who mysteriously developed natural control over the virus 02/08/2022

https://www.insider.com/hiv-cures-cancer-treatment-natural-control-2022-8?amp

2 more people have been 'cured' of HIV — 1 man thanks to cancer treatment, and 1 woman who mysteriously developed natural control over the virus Two more patients were announced functionally "cured" of HIV during AIDS 2022. One had cancer, the other has naturally controlled the virus for years.

Spanish woman revives hope of finding a cure for HIV / AIDS 01/08/2022

https://euroweeklynews.com/2022/08/01/spanish-woman-revives-hope-of-finding-a-cure-for-hiv-aids/

Spanish woman revives hope of finding a cure for HIV / AIDS A Spanish woman has revived hopes of finding a cure for HIV / AIDS having effectively managed her infection for more than 15 years with treatment.

Smart new single-cell assay shines a light on the HIV reservoir 31/07/2022

https://www.aidsmap.com/news/jul-2022/smart-new-single-cell-assay-shines-light-hiv-reservoir

Smart new single-cell assay shines a light on the HIV reservoir The International AIDS Conference in Montreal heard on Friday that for the first time scientists have developed a sensitive gene assay that can specifically find the tiny subset of ‘reservoir’ cells that harbour silent HIV infection by using nanotechnology to detect their distinct genetic signat...

Two HIV Patients Appear to Have Beaten Virus, Offering Hope for Cure 29/07/2022

https://www.wsj.com/amp/articles/two-older-hiv-patients-offer-new-clues-for-a-cure-11658930416

Two HIV Patients Appear to Have Beaten Virus, Offering Hope for Cure A 66-year-old man and a woman in her 70s appear to have beaten their HIV infections, offering hope and clues to researchers searching for a cure for the virus that causes AIDS.

A 5th person is likely cured of HIV, and another is in long-term remission 28/07/2022

https://www.nbcnews.com/news/amp/rcna40116

A 5th person is likely cured of HIV, and another is in long-term remission One case involved a man with cancer who underwent a specialized stem cell transplant; the other involved a woman who received immune-boosting therapies as part of a clinical trial.

Aids 2022 preview – Gilead shoots for an HIV cure 28/07/2022

https://www.evaluate.com/node/18044/amp

Aids 2022 preview – Gilead shoots for an HIV cure But progress – or lack thereof – with lenacapavir is a more immediate concern.

Fourth person 'cured' of HIV, but is a less risky cure in sight? 27/07/2022

https://amp.rfi.fr/en/international-news/20220727-fourth-person-cured-of-hiv-but-is-a-less-risky-cure-in-sight

Fourth person 'cured' of HIV, but is a less risky cure in sight? AIDS researchers announced on Wednesday that a fourth person has been "cured" of HIV, but the dangerous procedure for patients also battling cancer may be little comfort for the tens of millions living…

The continued search for a cure to HIV - 26/07/2022

https://pharmaphorum.com/r-d/the-continued-search-for-a-cure-to-hiv/

The continued search for a cure to HIV - Not very long ago, contracting HIV was an effective death sentence; today, there are treatments that allow the condition to be managed but not eradicated. Ben Hargreaves outlines how research is revealing new aspects of the virus and how the scientific community is making progress in the search for....

Novel HIV combination therapies could prevent viral escape and rebound 23/07/2022

https://www.washington.edu/news/2022/07/22/hiv-antibodies/

Novel HIV combination therapies could prevent viral escape and rebound New research by scientists at the University of Washington, the Max Planck Institute for Dynamics and Self-Organization and the University of Cologne indicates that carefully designed cocktails of...

How to select the best combination of antibodies to treat HIV 22/07/2022

https://www.drugtargetreview.com/news/104186/how-to-select-the-best-combination-of-antibodies-to-treat-hiv/

How to select the best combination of antibodies to treat HIV A new computer-based approach could help clinicians select the best combinations of antibodies to treat HIV based on the virus’ genetics.

One-time HIV treatment on the horizon after gene-editing breakthrough 21/07/2022

https://www.studyfinds.org/one-time-hiv-treatment/

One-time HIV treatment on the horizon after gene-editing breakthrough A team in Israel used gene-editing technology to engineer type B white blood cells, which can trigger the immune system to fight the virus.

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV 20/07/2022

https://www.news-medical.net/amp/news/20220720/Combinations-of-broadly-neutralizing-antibodies-may-be-a-more-effective-approach-to-treat-HIV.aspx

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.

Potential for HIV cure beyond the state of the ART? 20/07/2022

https://morningstaronline.co.uk/article/f/potential-hiv-cure-beyond-state-art

Potential for HIV cure beyond the state of the ART? Medicine has long been able to guarantee HIV patients an almost normal life and now it can fully cure the virus too — but the treatment is not appropriate for all, explain ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL

HIV Criminalization Laws Need to Change with Times, Advocates Say 19/07/2022

https://www.wknofm.org/2022-07-19/hiv-criminalization-laws-need-to-change-with-times-advocates-say

HIV Criminalization Laws Need to Change with Times, Advocates Say Advocates want lawmakers to reform a set of Tennessee laws passed before significant advancements in HIV treatment.

New affordable housing complex for people living with HIV opening this week 17/07/2022

https://www.kvue.com/amp/article/news/local/affordable-housing-complex-people-hiv-opening/269-ce2c2f4b-d552-4e47-b795-0bab589e757b

New affordable housing complex for people living with HIV opening this week Julia Smith with Project Transitions says having affordable housing for those with HIV is important to help treat them and stop the spread.